Quick answers
- What is Diovan?
- Diovan is a brand name of Valsartan, a prescription medicine. The FDA NDC Directory lists 7 Diovan products in 4 strengths and forms.
- Who makes Diovan?
- Novartis holds the FDA application for Diovan (NDA021283, approved July 18, 2001).
- Is there a generic or store brand of Diovan?
- Yes. The FDA NDC Directory lists 52 other products with the same active ingredients, strength and form as a Diovan product, 52 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Diovan?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 4 Diovan strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Diovan been recalled?
- FDA enforcement reports list 1 recall of Diovan products; the newest started August 4, 2026. A recall usually concerns specific lots, not every product.
What Diovan is
Each Diovan product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Valsartan · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| valsartan 160 mg tablet (oral) | Diovan | 13 products, 13 companies | DailyMed |
| valsartan 320 mg tablet (oral) | Diovan | 13 products, 12 companies | DailyMed |
| valsartan 40 mg tablet (oral) | Diovan | 12 products, 12 companies | DailyMed |
| valsartan 80 mg tablet (oral) | Diovan | 14 products, 13 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Valsartan →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021283 | Novartis | July 18, 2001 | 7 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| valsartan 160 mg tablet | Brand: Diovan | $10.04 per tablet Generic of the same strength and form: $0.1057 per tablet |
| valsartan 320 mg tablet | Brand: Diovan | $12.69 per tablet Generic of the same strength and form: $0.1703 per tablet |
| valsartan 40 mg tablet | Brand: Diovan | $7.82 per tablet Generic of the same strength and form: $0.1000 per tablet |
| valsartan 80 mg tablet | Brand: Diovan | $9.33 per tablet Generic of the same strength and form: $0.0808 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Diovan
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Diovan products.
- Novartis Pharmaceuticals Corporation7 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
August 4, 2026 · Class II · Ongoing · D-0746-2026
Failed Dissolution Specifications
Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34 — Novartis Pharmaceuticals Corporation
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.